Skip to content

Our Products and Expertise

Commercial Pharmaceuticals

STERILE FOCUS BRANDS

REGIONAL BRANDS


Anaesthetics

Young adult African American female patient is being sedated while laying on operating table. Senior adult Caucasian female anesthesiologist is using medical equipment to sedate patient.

Aspen has a comprehensive portfolio of 20 mature Anaesthetics Brands, having acquired two complementary Anaesthetics portfolios from AstraZeneca and GSK. Our diverse product range includes general anaesthetics, muscle relaxants as well as a number of local anaesthetics including topical agents, making Aspen a leading global supplier in the Anaesthetics category (House of Anesthesia), outside of the USA.


Thrombosis

Anesthetist

Our Thrombosis portfolio is a global offering (excluding USA) which is comprised largely of a broad range of specialist injectable anticoagulants. In addition to the heparin based anticoagulant portfolio, Aspen also produces Arixtra, a Xa inhibitor with a wide range of indications, including VTE treatment and prophylaxis, deep vein thrombosis, pulmonary embolism and acute coronary syndrome treatment.

High Potency & Cytotoxics, Women's Health and Pain Management

African American pharmacy customer uses a smart phone app to pay for his purchase. The pharmacist is scanning the smart phone.

Our Regional Brands are geographically diverse and include products for high Potency & Cytotoxics, Women's Health and Pain Management. The products within this segment have strong brand equity and are actively promoted through our experienced regional marketing and sales teams.

 

 

Looking for more information?

Get in touch to learn more about our products and services

Key Products
  • Diprivan
  • Emla
  • Marcaine
  • Naropin
  • Ultiva
  • Xylocaine
Key Products
  • Arixtra
  • Fraxiparine
  • Orgaran

 

 

Key Products
  • Eltroxin
  • Gracial
  • Imuran
  • Ovestin
  • Solpadeine
  • Zyloric

Commercial Pharmaceuticals

STERILE FOCUS BRANDS


Anaesthetics

Young adult African American female patient is being sedated while laying on operating table. Senior adult Caucasian female anesthesiologist is using medical equipment to sedate patient.

Aspen has a comprehensive portfolio of 20 mature Anaesthetics Brands, having acquired two complementary Anaesthetics portfolios from AstraZeneca and GSK. Our diverse product range includes general anaesthetics, muscle relaxants as well as a number of local anaesthetics including topical agents, making Aspen a leading global supplier in the Anaesthetics category, outside of the USA.

Key Products
  • Diprivan
  • Emla
  • Marcaine
  • Naropin
  • Ultiva
  • Xylocaine


Thrombosis

Anesthetist

Our Thrombosis portfolio is a global offering (excluding USA) which is comprised largely of a broad range of specialist injectable anticoagulants. In addition to the heparin based anticoagulant portfolio, Aspen also produces Arixtra, a Xa inhibitor with a wide range of indications, including CTE treatment and prophylaxis, deep vein thrombosis, pulmonary embolism and acute coronary syndrome treatment.

Key Products
  • Arixtra
  • Fraxiparine
  • Orgaran

REGIONAL BRANDS

High Potency & Cytotoxics, Women's Health and Pain Management

African American pharmacy customer uses a smart phone app to pay for his purchase. The pharmacist is scanning the smart phone.

Our Regional Brands are geographically diverse and include products for high Potency & Cytotoxics, Women's Health and Pain Management. The products within this segment have strong brand equity and are actively promoted through our experienced regional marketing and sales teams.

Key Products
  • Eltroxin
  • Gracial
  • Imuran
  • Ovestin
  • Solpadeine
  • Zyloric

Looking for more information?

Get in touch to learn more about our products and services

Scroll To Top